neurocare, a Munich, Germany-based personalized mental health care company, raised EUR 16M in funding.
TVM Capital Healthcare made the investment.
The company intends to use the funds to expand its international growth plans, including US and market entry into the Kingdom of Saudi Arabia, as well as support the development of new hardware and software innovations.
Led by CEO and Founder Thomas Mechtersheimer, neurocare is a healthcare company that offers an integrated, personalized treatment based on clinical evidence. Its digital therapy platform (DTP) is empowering doctors to offer their patients the best care for a variety of psychological or neurological conditions. Following a detailed assessment of the patient’s condition, neurocare supports clinicians in developing individualized therapy plans that are designed to lead to sustainable outcomes for patients, improving their self-regulation, resilience and social skills, while being cost effective for the healthcare system. These therapy plans integrate innovative methods and tools, such as psychotherapy, neuromodulation and sleep hygiene, as well as medication, to best help each individual patient.
neurocare’s DTP is currently used in the company’s clinics across the US, the Netherlands and Australia, as well as in a growing number of third-party clinics.
Commenting on the news, Thomas Mechtersheimer said: “We are very pleased to announce the cooperation with TVM Capital Healthcare, a strong partner with deep industry experience. This partnership allows us to accelerate neurocare’s growth in our key markets in the US, Europe and Australia and expand our geographic footprint into new regions. The implementation of our Digital Therapy Platform into clinics in the MENA region represents a new milestone in our company’s growth. I want to thank all involved parties, especially bm-t Thüringen, Aescuvest and Goerg Lawyers, for their advice and support in closing this financing.“
FinSMEs
24/04/2024